“The @SenFinance Committee… announced its second drug pricing hearing of 2019, with its leadership insisting on attendance from the executives of seven major drug manufacturers: AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., Pfizer, and Sanofi.”
-
-
Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.